Close
ACHEMA MIDDLE EAST 2026

Canadian And US Developers To Test Psychedelic Drugs In UK

To take advantage of the UK's quick medication approval procedures, the North American psychedelic drug companies Mindset, PharmAla, Mydecine, and Psyence have inked a...

Future Biotech Platforms Likely To Depend Primarily On Urine

A mechanism that employs urea to begin the manufacturing of proteins in the massive amounts required by the biotech industry has been developed by...

NICE Methodology Raises Concerns For Kidney Research UK

 The National Institute for Health and Care Excellence's (NICE) draught guidance on medicines for COVID-19 patients has received a response from Kidney Research UK. It...

As Per The WHO Assessment, AMR Monitoring Must Be Enhanced

Common bacterial illnesses are getting more and more resistant to treatments, according to the World Health Organization's (WHO) Global Antimicrobial Resistance and Use Surveillance...

Market For Oligonucleotides Forecast To Hit $16.7bn By 2027

The growth in ongoing clinical trials for oligonucleotide-based therapies in important therapeutic fields like oncology is expected to cause the global oligonucleotide synthesis market...

New Decoy Medication Neutralises COVID-19 And Variations

Dana-Farber scientists have developed a medication that neutralises SARS-CoV-2, the COVID-19 coronavirus, and every other tested version. The medicine is developed so that natural...

Addressing Cholestatic Liver Disease Upon Cognitive Decline

Cholestatic Bile flow can be hampered by liver conditions like primary biliary cholangitis (PBC), which can result in neurological problems. There is presently no known...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...